Is Biotricity Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BTCY) stock is to Buy BTCY stock.
Out of 1 analyst, 0 (0%) are recommending BTCY as a Strong Buy, 1 (100%) are recommending BTCY as a Buy, 0 (0%) are recommending BTCY as a Hold, 0 (0%) are recommending BTCY as a Sell, and 0 (0%) are recommending BTCY as a Strong Sell.
What is BTCY's forecast return on equity (ROE) for 2024-2026?
(NASDAQ: BTCY) forecast ROE is N/A, which is considered weak.
What is BTCY's Price Target?
According to 1 Wall Street analyst that have issued a 1 year BTCY price target, the average BTCY price target is $4.00, with the highest BTCY stock price forecast at $4.00 and the lowest BTCY stock price forecast at $4.00.
The Wall Street analyst predicted that Biotricity's share price could reach $4.00 by Jul 5, 2024. The average Biotricity stock price prediction forecasts a potential upside of 82.65% from the current BTCY share price of $2.19.
What is BTCY's forecast return on assets (ROA) for 2024-2026?
(NASDAQ: BTCY) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 0%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.